A Study of DXC014 in Patients With Advanced Solid Tumors.

Clinical trial NCT07177937 · RECRUITING

Trial details

NCT number: NCT07177937
Sponsor: Hangzhou DAC Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer Melanoma Prostate Cancer Other Advanced Solid Tumors

Start date: 2026-03-03
Primary completion: 2030-10-20
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.